CLASS II Drug recall · Reported 30 Mar 2022 · FDA Enforcement Report

Phenylephrine HCl Injection 50 mg recalled by Athenex Pharma Solutions

Athenex Pharma Solutions is recalling Phenylephrine HCl Injection 50 mg per in 0.9% Sodium Chloride, 50 mg excel, distributed nationwide in the US. The recall was initiated on 14 Mar 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: F2101652, F2101653, Exp 5/30/22; F2200111, Exp 7/27/22
Quantity recalled1,800 bags

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0710-2022
FDA event ID
89779
Recalling firm
Athenex Pharma Solutions, Clarence, NY
Classification
Class II
Status
Terminated
Recall initiated
14 Mar 2022
FDA classified
21 Mar 2022
Reported
30 Mar 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

14 Mar 2022Recall initiated by company
21 Mar 2022Classified by FDA+7 days
30 Mar 2022Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Defective container

Product as listed by the FDA

Phenylephrine HCl Injection 50 mg per 250 mL in 0.9% Sodium Chloride, 50 mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-494-15

Where it was distributed

USA nationwide.

Nationwide

Questions about this recall

Why was it recalled?

Defective container

Which lots are affected?

Lot #: F2101652, F2101653, Exp 5/30/22; F2200111, Exp 7/27/22

Where was it sold?

USA nationwide.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

6 other products · FDA event 89779

This product is part of a recall event; the main page for the event is Epinephrine Injection 8 mg per in 0.9% Sodium Chloride, 8mg excel recalled.

More recalls from Athenex Pharma Solutions

All 7

Other Phenylephrine Per recalls

All 4